Sabrina Urwyler, Associate Director Regulatory Affairs & Project Management, attended the Life Science Zurich Impact Conference on “Precision Medicine and AI Innovations,” where experts from academia, healthcare, and research gathered to explore the transformative role of artificial intelligence in medical treatment. Discussions addressed both the potential and the challenges of these technologies in advancing translational medicine.